Sage Journals: Discover world-class research

Abstract

Quercetagetin (QG) is a naturally occurring flavonoid found in marigold (Tagetes erecta). It has garnered attention for its potential to support immune health, regulate blood sugar levels, and enhance metabolism. Yet, unlike the closely related compound quercetin (QC), QG has an extra hydroxyl (-OH) group at the C-6 position of the flavonoid A-ring, whereas quercetin has only a hydrogen atom at that position, which has raised safety concerns. QG has not been thoroughly studied for long-term safety. To fill this gap, we conducted a 90-day study in rats to assess the response to repeated oral doses of QG. The QG-administered group of animals received 500, 1000, or 3000 mg/kg bw per day, and we monitored a wide range of health indicators, from body weight and food intake to blood chemistry, hormone levels, and indicators of organ health. The results were reassuring as there were no changes in the urine parameters, deaths, clinical signs, or changes in growth or eye health. Changes were non-adverse and/or of no significant toxicological concern in blood, and organ weight differences were minor and not associated with any tissue damage. Based on these findings, the No Observed Adverse Effect Level (NOAEL) was established at 3000 mg/kg bw/day, the highest dose tested.

We also tested QG for mutagenicity/clastogenicity using standard genotoxic assays, including bacterial mutation tests and micronucleus assays in CHO-k1 cells (in vitro) and Swiss albino mice (in vivo). Across all systems, QG showed no evidence of mutagenicity and/or clastogenicity.

Keywords

QG sub-chronic toxicity genotoxicity safety assessment

Get full access to this article

View all access options for this article.

References

Harvey

. Natural products in drug discovery. Drug Disc Today. 2008;13:894-901. doi:10.1016/j.drudis.2008.07.004.

Newman

Cragg

. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461-477. doi:10.1021/np068054v.

Panche

Diwan

Chandra

. Flavonoids: an overview. J Nutr Sci. 2016;5:e47. doi:10.1017/jns.2016.41. 29,

Gong

Liu

Yuan

Gao

. Investigation into the antioxidant activity and chemical composition of alcoholic extracts from defatted marigold (Tagetes erecta L.) residue. Fitoterapia. 2011;83:481-489. doi:10.1016/j.fitote.2011.12.013.

Wang

Chen

Tai

Liu

Gao

. In-vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residues. J Food Sci Technol. 2016;53:2614-2624. doi:10.1007/s13197-016-2228-6.

Rufino

Ramalho

Sousa

, et al. Protective role of flavonoids against intestinal pro-inflammatory effects of silver nanoparticles. Molecules. 2021;26:6610. doi:10.3390/molecules26216610.

Wang

Wei

Han

Chen

. Effects of dietary supplementation with quercetagetin on nutrient digestibility, intestinal morphology, immunity, and antioxidant capacity of broilers. Front Vet Sci. 2022;9:1060140. doi:10.3389/fvets.2022.1060140.

Ahmed-Belkacem

Guichou

Brillet

, et al. Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention. Nucleic Acids Res. 2014;42:9399-9409. doi:10.1093/nar/gku632.

Cotin

Calliste

Mazeron

, et al. Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication. Antiviral Res. 2012;96:181-186. doi:10.1016/j.antiviral.2012.09.010.

10.

Ullah

Munir

Badshah

, et al. Important flavonoids and their role as a therapeutic agent. Molecules. 2020;25:5243. doi:10.3390/molecules25225243.

11.

Harwood

Danielewska-Nikiel

Borzelleca

Flamm

Williams

Lines

. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 2007;45:2179-2205. doi:10.1016/j.fct.2007.05.015.

12.

Galati

O’Brien

. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004;37(3):287-303. doi:10.1016/j.freeradbiomed.2004.04.034.

13.

National Research Council (NRC) . Guide for the Care and Use of Laboratory Animals. 8th ed. https://www.ncbi.nlm.nih.gov/sites/books/NBK54053/

14.

Yadav

. CPCSEA guidelines for laboratory animal facility. Int J Pharmaceut Chem Res. 2020;2:09-13. doi:10.33545/26647613.2020.v2.i1a.10.

15.

OECD Test No. 408: repeated dose 90-Day oral toxicity study in rodents; 2018. https://www.oecd.org/en/publications/test-no-408-repeated-dose-90-day-oral-toxicity-study-in-rodents_9789264070707-en.html

16.

OECD . Test No. 474: Mammalian Erythrocyte Micronucleus Test. Paris: Organisation for Economic Co-operation and Development; 2016. https://www.oecd.org/en/publications/test-no-474-mammalian-erythrocyte-micronucleus-test_9789264264762-en.html

17.

OECD . Test No. 471: Bacterial Reverse Mutation Test. Paris: Organisation for Economic Co-operation and Development; 2020. doi:10.1787/9789264071247-en.

18.

Wang

Chen

Tai

Liu

Gao

. In vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residues. J Food Sci Technol. 2016;53(6):2614-2624. doi:10.1007/s13197-016-2228-6.

19.

NTP . Toxicology and carcinogenesis studies of Quercetin (CAS No. 117-39-5) in F344 rats (feed studies). Natl Toxicol Progr Tech Rep. 1992;409:1-171. https://pubmed.ncbi.nlm.nih.gov/12621521/

20.

Dunnick

Hailey

. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fund Appl Toxicol. 1992;19(Oct):423-431. doi:10.1016/0272-0590(92)90181-G.

21.

Harwood

Danielewska-Nikiel

Borzelleca

Flamm

Williams

Lines

22.

Lee

Kim

Park

. Genotoxicity assessment of quercetin glycosides using bacterial reverse mutation and in vitro chromosomal aberration tests. Food Chem Toxicol. 2018;112:385-392. doi:10.1016/j.fct.2017.12.045.

23.

Silva

Monteiro

Rocha

Silva

. Evaluation of genotoxic and mutagenic properties of flavonoids. Food Chem Toxicol. 2016;91:48-55. doi:10.1016/j.tiv.2007.07.008.

24.

Gaspar

Rodrigues

Laires

, et al. On the mechanisms of genotoxicity and metabolism of Quercetin. Mutagenesis. 1994;9:445-449. doi:10.1093/mutage/9.5.445.

25.

Utesch

Feige

Dasenbrock

, et al. Evaluation of the potential In-vivo genotoxicity of quercetin. Mutat Res. 2008;654:38-44. doi:10.1016/j.mrgentox.2008.04.008.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.43 MB

Pre-clinical Safety Assessment of Quercetagetin: Insights From Repeated-Dose Toxicity and Genotoxicity Studies

Abstract

Keywords

Get full access to this article

References

Supplementary Material